Literature DB >> 9246671

Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism.

M Gill1, G Daly, S Heron, Z Hawi, M Fitzgerald.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is a common condition of childhood the symptoms of which include inattention, excessive motor activity, inpulsivity and distractibility. It is strongly familial and twin and adoption studies suggest that the familiality is due, at least in part, to shared genes. Gillis et al found concordance rates in ADHD for MZ and DZ twins of 81% and 29% respectively. Stimulant drugs (eg, methylphenidate) are effective in the treatment of ADHD and inhibit the dopamine transporter. This has led to the development of a hypodopaminergic hypothesis for the disease. Cook et al examined a 3' variable number of tandem repeat (VNTR) polymorphism at the dopamine transporter gene (DAT1) in a sample of 49 ADHD patients and their parents, using the haplotype relative risk (HRR) method. They found a significant association (chi 2 = 7.29, 1 d.f., P = 0.007) between ADHD and the 480-bp DAT1 VNTR allele. The authors stressed the importance of independent replication and we have achieved this in a study of 40 probands and their parents, using the same robust HRR method. As in the study of Cook et al we found that the 480-bp allele was preferentially transmitted to ADHD probands (chi 2 = 6.07, 1 d.f., P = 0.014).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9246671     DOI: 10.1038/sj.mp.4000290

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  81 in total

1.  Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions.

Authors:  K L Lunetta; S V Faraone; J Biederman; N M Laird
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

Review 2.  Hyperactivity in children: a focus on genetic research and psychological theories.

Authors:  J Kuntsi; J Stevenson
Journal:  Clin Child Fam Psychol Rev       Date:  2000-03

Review 3.  Genes and attention deficit hyperactivity disorder.

Authors:  J Swanson; M Posner; J Fusella; M Wasdell; T Sommer; J Fan
Journal:  Curr Psychiatry Rep       Date:  2001-04       Impact factor: 5.285

4.  Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults.

Authors:  Guang Guo; Michael E Roettger; Jean C Shih
Journal:  Hum Genet       Date:  2006-10-31       Impact factor: 4.132

5.  Parent-of-origin effect and risk for attention-deficit/hyperactivity disorder: balancing the evidence against bias and chance findings.

Authors:  Ridha Joober; Sarojini Sengupta
Journal:  Am J Hum Genet       Date:  2006-10       Impact factor: 11.025

Review 6.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

7.  Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder.

Authors:  Tiffany A Greenwood; Eun-Jeong Joo; Tatyana Shekhtman; A Dessa Sadovnick; Ronald A Remick; Paul E Keck; Susan L McElroy; John R Kelsoe
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-12-19       Impact factor: 3.568

8.  Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study.

Authors:  C J Vaidya; G Austin; G Kirkorian; H W Ridlehuber; J E Desmond; G H Glover; J D Gabrieli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

9.  Attention-Deficit Hyperactivity Disorder in the post-genomic era.

Authors:  Philip Asherson
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

10.  Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11.

Authors:  Matthew N Ogdie; Simon E Fisher; May Yang; Janeen Ishii; Clyde Francks; Sandra K Loo; Rita M Cantor; James T McCracken; James J McGough; Susan L Smalley; Stanley F Nelson
Journal:  Am J Hum Genet       Date:  2004-08-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.